CPH.TO - Cipher Pharmaceuticals Inc.
| Previous Close | 3.9000 |
| Open | 3.9100 |
| Bid | 3.8200 x 0 |
| Ask | 3.8800 x 0 |
| Day's Range | 3.8000 - 3.9100 |
| 52 Week Range | 2.1400 - 4.0700 |
| Volume | |
| Avg. Volume | 15,298 |
| Market Cap | 97.793M |
| Beta (5Y Monthly) | 1.05 |
| PE Ratio (TTM) | 2.72 |
| EPS (TTM) | 1.4200 |
| Earnings Date | Aug 09, 2023 - Aug 14, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 11.08 |
CNW GroupCipher Pharmaceuticals Reports First Quarter Results, Highlighted by Record Cash Per Share and Strong Financial Flexibility
Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced its financial and operating results for the three month period ended March 31, 2023.
CNW GroupCipher Pharmaceuticals Schedules Q1 2023 Earnings Release and Conference Call
Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced that it will release its financial results for the first quarter of 2023 on Thursday, May 11, 2023. The Company will also host a conference call on Friday, May 12, 2023 at 8:30am ET to discuss the results and corporate developments.
- Newsfile
Cipher Pharmaceuticals to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference
Mississauga, Ontario--(Newsfile Corp. - April 18, 2023) - Cipher Pharmaceuticals (TSX: CPH), a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, will be participating in the 2023 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 25 and 26 at the Metro Toronto Convention Centre.Dates:Tuesday April 25, 2023 and Wednesday April 26, 2023Time:8:30 AM - 4:30 PM ETLocation: Metro Toronto Convention Centre,North
CNW GroupCipher Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results
Cipher Pharmaceuticals Inc. (TSX:CPH) ("Cipher" or "the Company") today announced its financial and operating results for the year ended December 31, 2022.
CNW GroupCipher Pharmaceuticals Schedules Q4 2022 Earnings Release and Conference Call
Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced that it will release its financial results for the three and twelve months ended December 31, 2022 after market close on March 16, 2023. The Company will also host a conference call on Friday, March 17, 2023 at 8:30am ET to discuss the results and corporate developments.
CNW GroupCipher Pharmaceuticals Announces Closing of New US$35 Million Credit Facility
Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced completion and closing of a new credit facility (the "Credit Facility") with Royal Bank of Canada (RBC).
Simply Wall St.Is Now The Time To Put Cipher Pharmaceuticals (TSE:CPH) On Your Watchlist?
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
- Simply Wall St.
Cipher Pharmaceuticals (TSE:CPH) shareholders have earned a 51% CAGR over the last three years
It might be of some concern to shareholders to see the Cipher Pharmaceuticals Inc. ( TSE:CPH ) share price down 12% in...
- Baystreet
Cipher, Loblaw at 52-Week Highs
Cipher Pharmaceuticals Inc. (T.CPH) hit a new 52-week high of $3.97 Friday. No news stories available ...
- ACCESSWIRE
Stock Pitch World Cup(TM), Educational Panels and 49 Companies to Present at the Planet MicroCap Showcase: VIRTUAL on December 6-8, 2022
The Planet MicroCap Showcase: VIRTUAL taking place on December 6-8, 2022, where 49 MicroCap public companies will be presenting virtually.
- Simply Wall St.
Cipher Pharmaceuticals Inc.'s (TSE:CPH) Stock Is Going Strong: Have Financials A Role To Play?
Cipher Pharmaceuticals (TSE:CPH) has had a great run on the share market with its stock up by a significant 30% over...
- Simply Wall St.
Cipher Pharmaceuticals Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues Lag
Cipher Pharmaceuticals ( TSE:CPH ) Third Quarter 2022 Results Key Financial Results Revenue: US$4.79m (up 6.2% from 3Q...
CNW GroupCipher Pharmaceuticals Reports Strong Third Quarter Results, Highlighted by USD$1.09 in Cash Per Share
Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced its financial and operating results for the three and nine month periods ended September 30, 2022. Unless otherwise noted, all figures are in U.S. dollars.
CNW GroupCIPHER PHARMACEUTICALS SCHEDULES Q3 2022 EARNINGS RELEASE AND CONFERENCE CALL
Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced that it will release its Q3 2022 financial results on Thursday, November 10, 2022 after market close. The company will hold a conference call on Friday, November 11, 2022 at 8:30am ET to discuss the results and corporate developments.
CNW GroupCipher Pharmaceuticals Announces Normal Course Issuer Bid
Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or the "Company") announced today that it has filed, and the Toronto Stock Exchange (the "TSX") has accepted, notice of Cipher's intention to commence a normal course issuer bid ("NCIB") for its common shares (the "Common Shares").
- Baystreet
Signa, Boardwalktech, Cipher at 52-Week Highs
Sigma Lithium Corporation (V.SGML) hit a new 52-week high of $37.76 Wednesday. No news stories available ...
- Baystreet
Africa Oil Hits 52-Week High on News
Africa Oil Corp. (T.AOI) hit a new 52-week high of 38.5 cents Tuesday. Africa Oil will host a physical ...
- Simply Wall St.
Investing in Cipher Pharmaceuticals (TSE:CPH) three years ago would have delivered you a 107% gain
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...
CNW GroupCipher Pharmaceuticals Strengthens Leadership Team with Appointment of New CFO
Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced the appointment of senior finance executive Bryan Jacobs as Chief Financial Officer ("CFO") effective August 15, 2022.
CNW GroupCipher Pharmaceuticals Reports Second Quarter 2022 Financial Results
Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced its financial and operating results for the three and six month periods ended June 30, 2022. Unless otherwise noted, all figures are in U.S. dollars.
CNW GroupCipher Pharmaceuticals Schedules Q2 2022 Earnings Release and Conference Call
Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced that it will release its Q2 2022 financial results on Thursday, August 11, 2022 after market close. The Company will also host a conference call on Friday, August 12, 2022 at 8:30am ET to discuss the results and corporate developments.
- Simply Wall St.
Should Weakness in Cipher Pharmaceuticals Inc.'s (TSE:CPH) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
With its stock down 3.8% over the past three months, it is easy to disregard Cipher Pharmaceuticals (TSE:CPH). But if...
CNW GroupCipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders and Thanks Director Dr. John Mull
Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or the "Company") today announced that it held its annual and special meeting of shareholders earlier today and that all matters put forward before shareholders for consideration and approval as set out in the Company's management information circular dated May 13, 2022 were approved by the requisite majority of votes cast at the meeting. In particular, shareholders approved the election of all director nominees, the re-approval of Ernst & Young L